Mechanisms of Resistance to Immunotherapy and Targeted Therapy and Predictive Biomarkers in Non-small Cell Lung Cancer

3,939
Total downloads
16k
Total views and downloads

Articles

SYSTEMATIC REVIEW

Published on 11 Sep 2025

The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials

Yun Xu
Baoliang Zhong
Chunlin Yu
Qingjian Hou
Wenying Chen
Wen Zheng
Wenxiong Zhang
Tonggang Zhou

doi 10.3389/fonc.2025.1590017

1,299 views

ORIGINAL RESEARCH

Published on 05 Sep 2025

Assembly factor for spindle microtubules (ASPM) promotes osimertinib resistance in lung cancer by increasing EGFR stability

Pengpeng Gui
Zhengyi Han
Zhenyu Yin
Peng Cao
Xin Zhou
Yan Li

doi 10.3389/fgene.2025.1593314

1,741 views

ORIGINAL RESEARCH

Published on 09 Jun 2025

Bioinformatics analysis identifies ZBTB16 as a potential immune biomarker for lung cancer and pan-cancer

Danfei Shi
Yunxiang Cai
Di Zhu
Xinmin Li
Yong Li

doi 10.3389/fgene.2025.1541732

1,756 views

ORIGINAL RESEARCH

Published on 26 Mar 2025

Multi-omics pan-cancer analysis reveals the diagnostic and prognostic value of C8orf76, with experimental validation of its impact on lung adenocarcinoma cell proliferation

Xiaohong Zhong
Zhiyong Zhang
Rongjing Gao
Shiqi Ren
Shifang Li
Miao Zhang
Jie Fang
Yanjiao Hou

doi 10.3389/fgene.2025.1524422

1,676 views

ORIGINAL RESEARCH

Published on 12 Dec 2024

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

Valérie Labrie
Judith Lefebvre
Catherine Labbé
Kevin Jao
Mandy Malick
Serge Simard
Nicole Bouchard

doi 10.3389/fonc.2024.1506172

1,206 views
1 citation

CASE REPORT

Published on 20 Sep 2024

Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion

Dong Qiu
Xiao-Hui Zhang
Yang Wang
Cheng Chen

doi 10.3389/fonc.2024.1404173

1,266 views
1 citation

SYSTEMATIC REVIEW

Published on 09 Jul 2024

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

Giulia Pasello
Alberto Pavan
Mattia De Nuzzo
Stefano Frega
Alessandra Ferro
Alessandro Dal Maso
Laura Bonanno
Valentina Guarneri
Fabio Girardi

doi 10.3389/fonc.2024.1415470

2,637 views
3 citations

ORIGINAL RESEARCH

Published on 25 Jun 2024

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

Min Zhang
Liang Zhu
Sibei Liang
Zhirong Mao
Xiaolin Li
Lingge Yang
Yan Yang
Kai Wang
Pingli Wang
Weiyu Chen

doi 10.3389/fonc.2024.1411436

1,803 views
2 citations

Share on

Frontiers in Genetics

Cancer Genetics and Oncogenomics

Impact

16kTopic views
12kArticle views
3,939Article downloads

View impact

Articles

The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials

Assembly factor for spindle microtubules (ASPM) promotes osimertinib resistance in lung cancer by increasing EGFR stability

Bioinformatics analysis identifies ZBTB16 as a potential immune biomarker for lung cancer and pan-cancer

Multi-omics pan-cancer analysis reveals the diagnostic and prognostic value of C8orf76, with experimental validation of its impact on lung adenocarcinoma cell proliferation

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

Frontiers in Genetics

Cancer Genetics and Oncogenomics